GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases
This cohort study assesses the association between glucagon-like peptide–1 receptor agonist (GLP-1 RA) use and survival in patients with type 2 diabetes and brain metastases.
Authors
- Chien‐Min Chen (ORCID: https://orcid.org/0000-0001-9838-0096)
- Pang‐Shuo Perng (ORCID: https://orcid.org/0000-0003-1102-2144)
- Hong-Min Lin
- Yu Chang
- Junmin Song
- Kuan-Yu Chi
Institutions
- National Chung Cheng University (TW)
- Jacobi Medical Center (US)
- Chi Mei Medical Center (TW)
- National Cheng Kung University Hospital (TW)
- Changhua Christian Hospital (TW)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.1311
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00